Explore Globally, Read Less, Discover More!
AsphaSearch is Asphalion’s AI-powered tool to perform global and local literature searches through a centralized, digital and regulatory-compliant platform.
Centralized access to both international sources and local regulatory databases.
Achieve up to 90% savings in Pharmacovigilance literature search activities.
Minimize manual tasks and accelerate literature search with validated AI technology.
Comprehensive digital logs to support audits and regulatory inspections.
Fully validated platform aligned with global pharmacovigilance guidelines.
Detect safety signals earlier and make informed decisions more quickly.
Artificial intelligence is reshaping Pharmacovigilance by increasing efficiency, improving collaboration, and enabling earlier risk detection and mitigation. Here’s how AsphaSearch contributes to a smarter, faster and more transparent Pharmacovigilance system:
Automatic processing of large volumes of adverse event report data
Identify patterns and correlations in data
Forecasting potential risks
Improvements in communication & collaboration
Transparency and availability of data
Compare traditional processes with AsphaSearch AI-enhanced system:
The use of software for conducting literature searches in PV can be considered a highly useful and beneficial tool for Pharmacovigilance Departments, improving the efficiency, speed, quality of work and profitability of the activity.
The incorporation of advanced AI tools presents a significant opportunity to enhance this crucial procedure in PV, which typically consumes substantial time and resources.
However, it is essential to guarantee the validity and transparency of AI algorithms and maintain an adequate balance between automation and expert supervision in the area of PV.
At Asphalion, we blend digital innovation with the deep expertise of our technical team, ensuring an optimal balance between technology and expert oversight. This synergy allows us to provide a service of complete trust to our clients, positioning us as a strategic pharmacovigilance partner
ASPHALION offers expert consulting, strategic advice, operational support and full outsourcing services for all drug development stages
ASPHALION’s experts have delivered solutions to over 1,000 Pharmaceutical, Biotechnological and Medical Technology companies from more than 50+ countries in over 5,000 projects covering non-clinical and clinical development, CMC, dossier writing, regulatory procedures, vigilance, eSubmissions and data management for both medicinal products and medical devices.
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
If you are interested in our AsphaSearch Solutions, or wish to get in touch for a general enquiry, please contact us for more information.
Fill the form and we will contact you as soon as possible:
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-advertisement | 1 year | Set by the GDPR Cookie Consent plugin, this cookie records the user consent for the cookies in the "Advertisement" category. |
cookielawinfo-checkbox-analytics | 1 year | Set by the GDPR Cookie Consent plugin, this cookie records the user consent for the cookies in the "Analytics" category. |
cookielawinfo-checkbox-necessary | 1 year | Set by the GDPR Cookie Consent plugin, this cookie records the user consent for the cookies in the "Necessary" category. |
cookielawinfo-checkbox-others | 1 year | Set by the GDPR Cookie Consent plugin, this cookie stores user consent for cookies in the category "Others". |
CookieLawInfoConsent | 1 year | CookieYes sets this cookie to record the default button state of the corresponding category and the status of CCPA. It works only in coordination with the primary cookie. |
elementor | never | The website's WordPress theme uses this cookie. It allows the website owner to implement or change the website's content in real-time. |
viewed_cookie_policy | 1 year | The GDPR Cookie Consent plugin sets the cookie to store whether or not the user has consented to use cookies. It does not store any personal data. |
wpEmojiSettingsSupports | session | WordPress sets this cookie when a user interacts with emojis on a WordPress site. It helps determine if the user's browser can display emojis properly. |
Cookie | Duration | Description |
---|---|---|
_ga | 1 year 1 month 4 days | Google Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognise unique visitors. |
_ga_* | 1 year 1 month 4 days | Google Analytics sets this cookie to store and count page views. |
_gat_gtag_UA_* | 1 minute | Google Analytics sets this cookie to store a unique user ID. |
_gid | 1 day | Google Analytics sets this cookie to store information on how visitors use a website while also creating an analytics report of the website's performance. Some of the collected data includes the number of visitors, their source, and the pages they visit anonymously. |
Cookie | Duration | Description |
---|---|---|
VISITOR_INFO1_LIVE | 6 months | YouTube sets this cookie to measure bandwidth, determining whether the user gets the new or old player interface. |
VISITOR_PRIVACY_METADATA | 6 months | YouTube sets this cookie to store the user's cookie consent state for the current domain. |
YSC | session | Youtube sets this cookie to track the views of embedded videos on Youtube pages. |
yt-remote-connected-devices | never | YouTube sets this cookie to store the user's video preferences using embedded YouTube videos. |
yt-remote-device-id | never | YouTube sets this cookie to store the user's video preferences using embedded YouTube videos. |
yt.innertube::nextId | never | YouTube sets this cookie to register a unique ID to store data on what videos from YouTube the user has seen. |
yt.innertube::requests | never | YouTube sets this cookie to register a unique ID to store data on what videos from YouTube the user has seen. |